A number of other analysts also recently weighed in on CLXT. National Securities restated a buy rating and issued a $28.00 target price (down previously from $35.00) on shares of Calyxt in a research report on Thursday, August 8th. Zacks Investment Research downgraded Calyxt from a buy rating to a hold rating in a research report on Tuesday, July 23rd. One research analyst has rated the stock with a sell rating, two have given a hold rating and three have issued a buy rating to the company. Calyxt currently has an average rating of Hold and an average target price of $20.00.
NASDAQ:CLXT traded up $0.07 during mid-day trading on Thursday, reaching $7.72. The stock had a trading volume of 2,694 shares, compared to its average volume of 55,895. The firm has a 50 day moving average price of $7.24 and a two-hundred day moving average price of $12.84. The stock has a market capitalization of $251.46 million, a P/E ratio of -8.48 and a beta of 2.50. Calyxt has a one year low of $5.56 and a one year high of $19.30. The company has a debt-to-equity ratio of 0.23, a quick ratio of 15.94 and a current ratio of 15.96.
Hedge funds have recently made changes to their positions in the business. Gilder Gagnon Howe & Co. LLC bought a new stake in Calyxt in the first quarter valued at approximately $172,000. Bank of America Corp DE lifted its position in Calyxt by 14.8% in the fourth quarter. Bank of America Corp DE now owns 10,300 shares of the company’s stock valued at $106,000 after purchasing an additional 1,330 shares during the last quarter. River & Mercantile Asset Management LLP bought a new stake in Calyxt in the second quarter valued at approximately $146,000. Swiss National Bank bought a new stake in Calyxt in the second quarter valued at approximately $228,000. Finally, Granite Investment Partners LLC lifted its position in Calyxt by 87.9% in the first quarter. Granite Investment Partners LLC now owns 21,801 shares of the company’s stock valued at $383,000 after purchasing an additional 10,196 shares during the last quarter. Hedge funds and other institutional investors own 28.05% of the company’s stock.
Calyxt, Inc, a consumer-centric food- and agriculture-focused company, develops healthier specialty food ingredients and food crops using gene-editing technology for agriculture in the United States. It engages in the development of high oleic and low linolenic soybean product candidates; high fiber wheat; improved quality alfalfa product candidates; and cold storable and reduced browning potatoes.
Recommended Story: Holder of Record
Receive News & Ratings for Calyxt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calyxt and related companies with MarketBeat.com's FREE daily email newsletter.